124 related articles for article (PubMed ID: 2131116)
1. Malignant melanomas of the choroid and ruthenium applicators.
Huyghe JP; Verbraeken H; Goes F; De Wilde G; Hanssens M; Brabant P; Van Hijfte R; De Laey JJ
Bull Soc Belge Ophtalmol; 1990; 238():137-43. PubMed ID: 2131116
[TBL] [Abstract][Full Text] [Related]
2. [Retrospective analysis of ruthenium-106 brachytherapy for small and medium-sized malignant melanoma of the posterior choroid].
Stoffelns BM; Kutzner J; Jochem T
Klin Monbl Augenheilkd; 2002 Apr; 219(4):216-20. PubMed ID: 12022004
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of 100 melanomas of the choroid and ciliary body treated by application of ruthenium (RU 106 Rh 106)].
Grange JD; Gerard JP; Ragab M; Quintero P; Delaroche G; Jean-Louis B; Sentenac I; Fontaniere B; Bievelez B
Bull Soc Ophtalmol Fr; 1989 May; 89(5):679-82. PubMed ID: 2590984
[TBL] [Abstract][Full Text] [Related]
4. Ruthenium applicators in the treatment of choroidal melanomas.
Van Hijfte R; Verbraeken H; De Laey JJ
Bull Soc Belge Ophtalmol; 1987; 224():51-8. PubMed ID: 3509023
[No Abstract] [Full Text] [Related]
5. [Treatment of various malignant melanomas of the choroid using a combination of ruthenium 106 and cobalt 60].
Bacin F; Rozan R; Donnarieix D; Dalens H
Ophtalmologie; 1990; 4(3):225-8. PubMed ID: 2250952
[TBL] [Abstract][Full Text] [Related]
6. Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas.
Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):392-400. PubMed ID: 15990248
[TBL] [Abstract][Full Text] [Related]
7. Techniques and results of 106Ru/106Rh radiation of choroidal tumours.
Busse H; Müller RP
Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 1)():72-7. PubMed ID: 6581639
[TBL] [Abstract][Full Text] [Related]
8. Predicting local control of choroidal melanomas following ¹⁰⁶Ru plaque brachytherapy.
Papageorgiou KI; Cohen VM; Bunce C; Kinsella M; Hungerford JL
Br J Ophthalmol; 2011 Feb; 95(2):166-70. PubMed ID: 20889528
[TBL] [Abstract][Full Text] [Related]
9. [Prospective nonrandomised analysis of "Sandwich Therapy" for malignant melanoma of the choroid].
Stoffelns BM; Kutzner J; Schöpfer K; Frising M
Klin Monbl Augenheilkd; 2002 Apr; 219(4):211-5. PubMed ID: 12022003
[TBL] [Abstract][Full Text] [Related]
10. [Curietherapy using a ruthenium and iridium disk in the treatment of choroid melanoma].
Gérard JP; Grange JD; Romestaing P; Sentenac I; De Laroche G; Montbarbon X; Mahe M; Salerno N; Baude JP; Bonnet M
Ann Radiol (Paris); 1989; 32(2):107-11. PubMed ID: 2757334
[TBL] [Abstract][Full Text] [Related]
11. [Choroid melanoma. A retrospective randomized comparative study of ruthenium irradiation vs enucleation].
Guthoff R; Frischmuth J; Jensen OA; Bjerrum K; Prause JU
Klin Monbl Augenheilkd; 1992 Apr; 200(4):257-61. PubMed ID: 1614086
[TBL] [Abstract][Full Text] [Related]
12. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
13. [Conservative treatment of malignant choroid melanoma by scleral applicators of ruthenium-106. First 25 French cases].
Grange JD; Bonnet M; Gerard JP; Burillon C
Bull Soc Ophtalmol Fr; 1986 Apr; 86(4):523-6. PubMed ID: 3815691
[No Abstract] [Full Text] [Related]
14. [Treatment of choroid melanoma with contact curietherapy using ruthenium 106].
Muller RP; Busse H; Kroll P; Gast E
J Fr Ophtalmol; 1985; 8(10):639-43. PubMed ID: 3833880
[TBL] [Abstract][Full Text] [Related]
15. [Results of treatment of malignant melanoma of the choroid using local beta-irradiation (Ru106/Rh106) from 1988 to 1992].
Oláh Z; Furdová A
Cesk Oftalmol; 1994 Apr; 50(2):76-85. PubMed ID: 8200050
[TBL] [Abstract][Full Text] [Related]
16. [Motility disorders in brachytherapy of choroid melanomas with Ru106 applicators].
Langmann A; Langmann G; Unlücerci C; Haller E
Ophthalmologe; 1995 Feb; 92(1):76-8. PubMed ID: 7719082
[TBL] [Abstract][Full Text] [Related]
17. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
18. Local tumor control after 106Ru brachytherapy of choroidal melanoma.
Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):385-91. PubMed ID: 15913907
[TBL] [Abstract][Full Text] [Related]
19. [The role of beta-ray therapy in the treatment of choroidal and ciliary body melanomas].
Grange JD; Gérard JP; Ragab M; Delaroche G; Jean-Louis B; Bievelez B; Sentenac I; Baute B
Ophtalmologie; 1989; 3(3):175-9. PubMed ID: 2641104
[TBL] [Abstract][Full Text] [Related]
20. [Plexiglass replicas for optimizing selection and site of ruthenium 106 applicators].
Menapace R
Klin Monbl Augenheilkd; 1990 Jan; 196(1):40-2. PubMed ID: 2313993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
